Premium Content Preview | 5 Ways to save your hospital money with better communications
In this eBrief we look at why increasing the efficiency of critical test results management (CTRM) is of vitalimportance for your organization and your patients.
Potential Impact of Poor Communication
INTRODUCTION
The rising cost of delivering care and shrinking operating margins means that cost reduction is a constant initiative at hospitals and health systems across the U.S. Organizations are looking at everything from tighter supply controls to energy efficiency initiatives. Another avenue that hospitals are evaluating more closely is communications. Research studies have estimated that inefficient communications cost U.S. hospitals up to $12 billion per year, which breaks down to nearly $4 million annually for a 500-bed hospital.2 Inefficient communication is expensive because it wastes clinician time, delays patient treatment and discharge, and can contribute to costly medical errors. In this eBrief
we look at five ways hospitals can save money with better communications.
Download for all 5 ways to save your hospital money
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More
